Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients

J Antimicrob Chemother. 2005 Feb;55(2):280-1. doi: 10.1093/jac/dkh516. Epub 2005 Jan 13.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy
  • HIV Infections / metabolism*
  • Hepacivirus / drug effects*
  • Hepacivirus / metabolism
  • Hepatitis C / complications
  • Hepatitis C / drug therapy
  • Hepatitis C / metabolism*
  • Humans
  • Liver / drug effects
  • Liver / metabolism
  • Lopinavir
  • Male
  • Middle Aged
  • Pyrimidinones / pharmacokinetics
  • Pyrimidinones / toxicity*
  • Ritonavir / pharmacokinetics
  • Ritonavir / toxicity*

Substances

  • Pyrimidinones
  • Lopinavir
  • Ritonavir